These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 1727208)

  • 41. [Serum levels of soluble receptors of interleukin-2 in skin pathology].
    Massobrio R; Lisa F; Novelli M; Bernengo MG
    G Ital Dermatol Venereol; 1990 Feb; 125(1-2):1-6. PubMed ID: 2365399
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Soluble interleukin-2 receptors in sera of children with primary malignant neoplasms.
    Bodey B; Psenko V; Lipsey AL; Kaiser HE
    Anticancer Res; 1996; 16(1):219-24. PubMed ID: 8615612
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Soluble interleukin-2 receptor and soluble CD8 antigen levels in serum from patients with solid tumors.
    Orditura M; De Vita F; Roscigno A; Auriemma A; Infusino S; Catalano G
    Int J Mol Med; 1998 Jul; 2(1):75-9. PubMed ID: 9854147
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Cytokines (IL-6, TNF-alpha, IL-1alpha) and soluble interleukin-2 receptor as serum tumor markers in multiple myeloma.
    Filella X; Blade J; Guillermo AL; Molina R; Rozman C; Ballesta AM
    Cancer Detect Prev; 1996; 20(1):52-6. PubMed ID: 8907203
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Circulating LR11 is a novel soluble-receptor marker for early-stage clinical conditions in patients with non-Hodgkin's lymphoma.
    Fujimura K; Ebinuma H; Fukamachi I; Ohwada C; Kawaguchi T; Shimizu N; Takeuchi M; Sakaida E; Jiang M; Nakaseko C; Bujo H
    Clin Chim Acta; 2014 Mar; 430():48-54. PubMed ID: 24394293
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Comparison of serum NO, TNF-alpha, IL-1beta, sIL-2R, IL-6 and IL-8 levels with grades of retinopathy in patients with diabetes mellitus.
    Doganay S; Evereklioglu C; Er H; Türköz Y; Sevinç A; Mehmet N; Savli H
    Eye (Lond); 2002 Mar; 16(2):163-70. PubMed ID: 11988817
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Serum levels of helper factors (IL-1 alpha, IL-1 beta and IL-6), T-cell products (sCD4 and sCD8), sIL-2R and beta 2-microglobulin in patients with B-CLL and benign B lymphocytosis.
    Aguilar-Santelises M; Loftenius A; Ljungh C; Svenson SB; Andersson B; Mellstedt H; Jondal M
    Leuk Res; 1992; 16(6-7):607-13. PubMed ID: 1386130
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Granulocyte-colony-stimulating factor induces increased serum levels of soluble interleukin 2 receptors preceding engraftment in autologous bone marrow transplantation.
    Dreger P; Grelle K; Eckstein V; Suttorp M; Müller-Ruchholtz W; Löffler H; Schmitz N
    Br J Haematol; 1993 Jan; 83(1):7-13. PubMed ID: 7679589
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Serum soluble interleukin-2 receptors as an index of the biological activity of thyroid hormones in hyperthyroidism.
    Koukkou E; Panayiotidis P; Thalassinos N
    J Endocrinol Invest; 1995 Apr; 18(4):253-7. PubMed ID: 7560805
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Clinical significance of soluble interleukin-2 receptor levels in the cerebrospinal fluid in patients with adult T-cell leukemia complicated with meningeal infiltration].
    Tanaka K; Shiraishi K; Sakamoto A; Okubo Y; Fukuda Y; Fukahori S; Jojima H; Osabe S; Honda J; Natori H; Oizumi K
    Gan To Kagaku Ryoho; 1996 Jun; 23(7):863-9. PubMed ID: 8678534
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Comparison of serum sIL-2R and LDH levels in patients with intravascular large B-cell lymphoma and patients with advanced stage diffuse large B-cell lymphoma.
    Hirami Y; Nishimura MF; Urata T; Morimoto M; Maekawa Y; Yoshino T; Nishimura Y; Sato Y
    J Clin Exp Hematop; 2023 Mar; 63(1):25-31. PubMed ID: 36843068
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Serum level of soluble interleukin-2 receptor correlates with CD25 expression in patients with T lymphoblastic lymphoma.
    Toji T; Takata K; Sato Y; Miyata-Takata T; Hayashi E; Habara T; Maeda Y; Tanimoto M; Yoshino T
    J Clin Pathol; 2015 Aug; 68(8):622-7. PubMed ID: 25935549
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [The role of serum soluble interleukin 2 receptor (sIL-2R) levels in patients with renal cell carcinoma].
    Akiyama K; Tsuji M; Kurokawa Y; Yokota K; Kojima K; Naruo S; Kanayana HO; Kagawa S
    Nihon Hinyokika Gakkai Zasshi; 1997 Apr; 88(4):473-8. PubMed ID: 9155114
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Significance of soluble interleukin-2 receptor levels for evaluation of the progression of adult T-cell leukemia.
    Kamihira S; Atogami S; Sohda H; Momita S; Yamada Y; Tomonaga M
    Cancer; 1994 Jun; 73(11):2753-8. PubMed ID: 8194016
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Serum soluble interleukin-2 receptor levels in patients with renal cell carcinoma: a comparison of values before and after surgery].
    Tsukamoto S; Ishikawa S; Yamauchi A; Saitou S
    Hinyokika Kiyo; 2000 Oct; 46(10):695-9. PubMed ID: 11215193
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Circulating levels of intercellular adhesion molecule-1 (ICAM-1) and soluble interleukin 2 receptors (IL-2R) in patients with B cell chronic lymphocytic leukaemia.
    Musolino C; Alonci A; Allegra A; Bellomo G; Spatari G; Pernice F; Squadrito G; Quartarone C; Tringali O; Quartarone M
    Riv Eur Sci Med Farmacol; 1996; 18(3):113-8. PubMed ID: 9177607
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Interleukins, TNF-alpha and beta-2M in patients with B cell chronic lymphocytic leukemia.
    Mavridis AK; Tsiara S; Makis A; Chaidos A; Christou L; Seferiadis K; Bourantas KL
    J Exp Clin Cancer Res; 1998 Dec; 17(4):445-8. PubMed ID: 10089066
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The significance of soluble interleukin-2 receptor in monitoring disease relapse in patients with nasopharyngeal cancer.
    Wu LJ; Chen KY; Chi KH; Chen SY; Liang MJ; Shiau CY; Wang LW; Liu YM; Chow KC; Yen SH
    Jpn J Clin Oncol; 1998 Dec; 28(12):729-32. PubMed ID: 9879289
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Serum beta 2-microglobulin in malignant lymphoproliferative disorders.
    Melillo L; Musto P; Tomasi P; Cascavilla N; Bodenizza C; Ladogana S; Carotenuto M
    Tumori; 1988 Apr; 74(2):129-35. PubMed ID: 3285553
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Serum levels of soluble IL-6 receptor in multiple myeloma as indicator of disease activity.
    Papadaki H; Kyriakou D; Foudoulakis A; Markidou F; Alexandrakis M; Eliopoulos GD
    Acta Haematol; 1997; 97(4):191-5. PubMed ID: 9158660
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.